Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,478 | 180,904 | 129,972 | 135,156 | 149,569 |
| Receivables | 97,422 | 80,724 | 78,129 | 55,789 | 51,255 |
| Inventories | 7,713 | 6,508 | 5,518 | 3,611 | 3,431 |
| TOTAL | $295,915 | $276,571 | $228,972 | $207,783 | $218,875 |
| Non-Current Assets | |||||
| PPE Net | 971 | 1,016 | 1,064 | 1,156 | 1,242 |
| Other Non-Current Assets | 30,189 | 27,533 | 29,113 | 31,350 | 30,103 |
| TOTAL | $31,160 | $28,549 | $30,177 | $32,506 | $31,345 |
| Total Assets | $327,075 | $305,120 | $259,149 | $240,289 | $250,220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,361 | 6,365 | 4,983 | 1,075 | 4,008 |
| Accrued Expenses | 110,463 | 84,993 | 91,664 | 67,113 | 66,051 |
| Other current liabilities | 37,283 | 33,016 | 34,749 | 24,344 | 21,526 |
| TOTAL | $153,777 | $125,041 | $132,044 | $93,123 | $91,823 |
| Non-Current Liabilities | |||||
| Long Term Debt | 164,587 | 163,675 | 209,087 | 207,093 | 205,139 |
| Other Non-Current Liabilities | 352,984 | 353,359 | 356,187 | 362,607 | 359,092 |
| TOTAL | $517,571 | $517,034 | $565,274 | $569,700 | $564,231 |
| Total Liabilities | $671,348 | $642,075 | $697,318 | $662,823 | $656,054 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,901 | 79,756 | 78,799 | 71,138 | 70,944 |
| Common Shares | 8 | 7 | 6 | 6 | 6 |
| Retained earnings | -1,532,209 | -1,514,627 | -1,484,258 | -1,463,110 | -1,433,137 |
| TOTAL | $-344,273 | $-336,955 | $-438,169 | $-422,534 | $-405,834 |
| Total Liabilities And Equity | $327,075 | $305,120 | $259,149 | $240,289 | $250,220 |